ARCHIVES

Phase III Study Evaluating Halaven Fails To Meet Primary Endpoints

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

ACS Board Tables Proposal For Accepting State, Local Funds

December 3, 1993

Clinical Trials Approved By NCI CTEP During July

August 30, 2002

Five Awards Expected In Annual CCP Review; 21 Applicants Compete For Limited Funding

February 1, 1991

In Brief: Pinedo To Receive Josef Steiner Prize; Lurie Cancer Center Gets $2.5M Donation

October 27, 1995

Shubik Group Finishes Criteria, Presents Final Draft To Rauscher

July 2, 1976

NKTR-102 Shows 29 Percent Response in Phase II Study

September 30, 2011